British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom
Leung, Elaine Yl Nicum, Shibani Morrison, Jo Brenton, James D Funingana, Ionut-Gabriel Morgan, Robert D Ghaem-Maghami, Sadaf Miles, Tracie Manchanda, Ranjit Bowen, Rebecca
Leung, Elaine Yl
Nicum, Shibani
Morrison, Jo
Brenton, James D
Funingana, Ionut-Gabriel
Morgan, Robert D
Ghaem-Maghami, Sadaf
Miles, Tracie
Manchanda, Ranjit
Bowen, Rebecca
Citations
Altmetric:
Affiliation
University of Birmingham; University College London; Musgrove Park Hospital Grace Centre; Sandwell and West Birmingham NHS Trust; et al.
Other Contributors
Publication date
2024-09-02
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Standard of care genetic testing has undergone significant changes in recent years. The British Gynecological Cancer Society and the British Association of Gynecological Pathologists (BGCS/BAGP) has re-assembled a multidisciplinary expert consensus group to update the previous guidance with the latest standard of care for germline and tumor testing in patients with ovarian cancer. For the first time, the BGCS/BAGP guideline group has incorporated a patient advisor at the initial consensus group meeting. We have used patient focused groups to inform discussions related to reflex tumor testing - a key change in this updated guidance. This report summarizes recommendations from our consensus group deliberations and audit standards to support continual quality improvement in routine clinical settings.
Citation
Leung EY, Nicum S, Morrison J, Brenton JD, Funingana IG, Morgan RD, Ghaem-Maghami S, Miles T, Manchanda R, Bowen R, Andreou A, Loughborough W, Freeman S, Gajjar K, Coleridge S, Jimenez-Linan M, Balega J, Frost J, Keightley A, Wallis Y, Sundar S, Ganesan R. British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom. Int J Gynecol Cancer. 2024 Sep 2;34(9):1334-1343. doi: 10.1136/ijgc-2024-005756
Type
Article